Meg Elias
Corporate Officer/Principal chez ARCUTIS BIOTHERAPEUTICS, INC.
Profil
Meg Elias is currently the Vice President of Clinical Operations at Arcutis Biotherapeutics, Inc. Her former position was as Head of Clinical Operations at Kite Pharma, Inc. She received her undergraduate degree from Cedar Crest College.
Postes actifs de Meg Elias
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Meg Elias
| Sociétés | Poste | Fin |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01/12/2018 |
Formation de Meg Elias
| Cedar Crest College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |